Johnson & Johnson slipped as investors began to assess the potential long-term costs to the company of the legal saga surrounding its talc products.
On Thursday, a jury ordered the company to pay $4.69 billion to women who claimed asbestos in the products caused them to develop ovarian cancer, marking the sixth-largest product-defect verdict in U.S. history.
